Check out the latest issue of PharmaTimes Magazine, where our CEO Kirk Geale explains how global pharmaceutical executives can harness the power of Nordic health data.
Nordic RWD are globally unique and practitioners should not miss the opportunities available […]
In our latest publication in the Journal of Medical Economics, the cost-effectiveness of bimekizumab was assessed for the treatment of psoriatic arthritis in Sweden in collaboration with UCB and others.
According to Quantify Research co-author and payer expert Linnea […]
Hopes are high for the first disease modifying treatments in Alzheimer’s disease to be approved on the European market, but many challenges remain. Quantify Research colleagues Anders Gustavsson and Lena Jacobs are […]
Quantify’s Alexander Rieem Dun and Jonas Banefelt are co-authors on a recent publication on the effects of intensity and adherence to lipid-lowering treatment on the risk of cardiovascular events in patients with […]
Do you want to know more about the evidence behind pediatric pneumococcal conjugate vaccine (PCV) recommendations in Europe? Linked below is a recent publication, co-authored by Quantify’s Hanna Fues Wahl, that summarizes the findings from a systematic literature review of pediatric […]
Anders Gustavsson, partner vid Quantify, och professor Bengt Winblad vid Karolinska institutet har skrivit rapporten Alzheimers sjukdom – en utmaning för Sverige. Läs den här: Alzheimers sjukdom – en utmaning för Sverige 20210701. Rapporten syftar till att ge en […]
At Quantify Research, we support equality and diversity, and to honor pride month we want to highlight the work of our Lead Analyst, Christoph Abé, who recently published a large-scale imaging-genetics study […]
The unavailability of medicines can be both problematic and lead to severe consequences for patients in need of therapy. However, in many cases other treatment alternatives can be provided. Quantify, in collaboration […]
Quantify’s Emma Söreskog, Ingrid Lindberg, Oskar Ström and Fredrik Borgström have co-authored two recently published papers on cost-effectiveness modelling in osteoporosis. One of the papers presents a […]